Clinical Trials on Longitudinally Extensive Transverse Myelitis in Poland
Total 8 results
-
Hoffmann-La RocheRecruitingNeuromyelitis Optica Spectrum Disorder | NMOSDPoland, United Kingdom, Argentina, Italy, France, United States
-
AmgenRecruitingNeuromyelitis Optica Spectrum DisorderKorea, Republic of, Thailand, Hong Kong, Hungary, Poland
-
AmgenRecruitingNeuromyelitis Optica Spectrum DisorderUnited Kingdom, United States, Sweden, Netherlands
-
Hoffmann-La RocheChugai PharmaceuticalCompletedNeuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)Spain, Italy, United States, Japan, Poland, Taiwan, Germany, United Kingdom, Hungary, France, Ukraine
-
Hoffmann-La RocheActive, not recruitingNeuromyelitis Optica Spectrum DisorderUnited States, Spain, United Kingdom, Taiwan, Hungary, Korea, Republic of, Japan, Croatia, Bulgaria, Canada, Germany, Italy, Poland, Puerto Rico, Romania, Turkey, Ukraine, Malaysia
-
AlexionActive, not recruitingNeuromyelitis Optica | Neuromyelitis Optica Spectrum DisorderUnited States, Australia, Austria, Canada, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Spain, United Kingdom
-
Hoffmann-La RocheChugai PharmaceuticalCompletedNeuromyelitis Optica (NMO) | NMO Spectrum Disorder (NMOSD)United States, Korea, Republic of, Malaysia, Turkey, Bulgaria, Canada, Poland, Puerto Rico, Romania, Croatia, Georgia, Italy, Philippines, Taiwan, Ukraine
-
MedImmune LLCCompletedNeuromyelitis Optica and Neuromyelitis Optica Spectrum DisordersUnited States, Czechia, Thailand, Germany, Korea, Republic of, Israel, New Zealand, Spain, Taiwan, Japan, Turkey, Hungary, Bulgaria, Mexico, Russian Federation, Colombia, Peru, Poland, Estonia, South Africa, Canada, Australia, Hong... and more